BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 33228419)

  • 1. The investigation of T-cell receptor subtypes in ovarian cancer: effects on survival and prognostic factors.
    Özkan S; Selvi Gunel N; Aygünes D; Akman L; Yildirim N; Teti K Vardarli A; Özsaran A; Terek C
    J Obstet Gynaecol; 2021 Aug; 41(6):951-955. PubMed ID: 33228419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resolving T-cell receptor clonality in two and genotype in four multiplex polymerase chain reactions.
    Dictor M; Warenholt J; Isinger A
    Haematologica; 2005 Nov; 90(11):1524-32. PubMed ID: 16266900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nicotinamide N-methyltransferase overexpression may be associated with poor prognosis in ovarian cancer.
    Harmankaya İ; Akar S; Uğraş S; Güler AH; Ezveci H; Aydoğdu M; Çelik Ç
    J Obstet Gynaecol; 2021 Feb; 41(2):248-253. PubMed ID: 32285726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of three molecular subtypes based on immune infiltration in ovarian cancer and its prognostic value.
    Liu J; Tan Z; He J; Jin T; Han Y; Hu L; Song J; Huang S
    Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33043974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does sites of recurrence impact survival in secondary cytoreduction surgery for recurrent epithelial ovarian cancer?
    Kumar S; Srinivasan A; Phillips A; Madhupriya R; Pascoe J; Nevin J; Elattar A; Balega J; Cummins C; Sundar S; Kehoe ST; Singh K
    J Obstet Gynaecol; 2020 Aug; 40(6):849-855. PubMed ID: 31933417
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo.
    Zeng S; Liu S; Feng J; Gao J; Xue F
    Cancer Biomark; 2019; 24(4):421-428. PubMed ID: 30909184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mucinous borderline ovarian tumor versus invasive well-differentiated mucinous ovarian cancer: Difference in characteristics and outcomes.
    Matsuo K; Machida H; Mandelbaum RS; Grubbs BH; Roman LD; Sood AK; Gershenson DM
    Gynecol Oncol; 2019 May; 153(2):230-237. PubMed ID: 30797590
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Noncoding RNA (ncRNA) Profile Association with Patient Outcome in Epithelial Ovarian Cancer Cases.
    Oliveira DVNP; Prahm KP; Christensen IJ; Hansen A; Høgdall CK; Høgdall EV
    Reprod Sci; 2021 Mar; 28(3):757-765. PubMed ID: 33125686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
    Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
    APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR‑508‑3p suppresses the development of ovarian carcinoma by targeting CCNA2 and MMP7.
    Guo F; Zhang K; Li M; Cui L; Liu G; Yan Y; Tian W; Teng F; Zhang Y; Gao C; Gao J; Wang Y; Xue F
    Int J Oncol; 2020 Jul; 57(1):264-276. PubMed ID: 32377701
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ratios of CD8+ T cells to CD4+CD25+ FOXP3+ and FOXP3- T cells correlate with poor clinical outcome in human serous ovarian cancer.
    Preston CC; Maurer MJ; Oberg AL; Visscher DW; Kalli KR; Hartmann LC; Goode EL; Knutson KL
    PLoS One; 2013; 8(11):e80063. PubMed ID: 24244610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical impact of EZH2 and its antagonist SMARCA4 in ovarian cancer.
    Leitner K; Tsibulak I; Wieser V; Knoll K; Reimer D; Marth C; Fiegl H; Zeimet AG
    Sci Rep; 2020 Nov; 10(1):20412. PubMed ID: 33230143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mTOR downstream regulator (p-4EBP1) is a novel independent prognostic marker in ovarian cancer.
    Alabdullah ML; Ahmad DA; Moseley P; Madhusudan S; Chan S; Rakha E
    J Obstet Gynaecol; 2019 May; 39(4):522-528. PubMed ID: 30712414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of GPNMB predicts an unfavorable outcome of epithelial ovarian cancer.
    Ma RQ; Tang ZJ; Ye X; Cheng HY; Sun KK; Chang XH; Cui H
    Arch Gynecol Obstet; 2018 May; 297(5):1235-1244. PubMed ID: 29428978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic impact of celiac lymph node involvement in patients after frontline treatment for advanced ovarian cancer.
    Angeles MA; Ferron G; Cabarrou B; Balague G; Martínez-Gómez C; Gladieff L; Pomel C; Martinez A
    Eur J Surg Oncol; 2019 Aug; 45(8):1410-1416. PubMed ID: 30857876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Surgery in early-stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].
    Bolze PA; Collinet P; Golfier F; Bourgin C
    Gynecol Obstet Fertil Senol; 2019 Feb; 47(2):168-179. PubMed ID: 30686727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in ovarian cancer survival during the 20 years before the era of targeted therapy.
    Lee JY; Kim S; Kim YT; Lim MC; Lee B; Jung KW; Kim JW; Park SY; Won YJ
    BMC Cancer; 2018 May; 18(1):601. PubMed ID: 29843633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunoglobulin and T-cell receptor gene rearrangement and expression in human lymphoid leukemia cells at different stages of maturation.
    Davey MP; Bongiovanni KF; Kaulfersch W; Quertermous T; Seidman JG; Hershfield MS; Kurtzberg J; Haynes BF; Davis MM; Waldmann TA
    Proc Natl Acad Sci U S A; 1986 Nov; 83(22):8759-63. PubMed ID: 3464980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical significance of miRNA-21, -103, -129, -150 in serous ovarian cancer.
    Wilczyński M; Żytko E; Danielska J; Szymańska B; Dzieniecka M; Nowak M; Malinowski J; Owczarek D; Wilczyński JR
    Arch Gynecol Obstet; 2018 Mar; 297(3):741-748. PubMed ID: 29335784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraepithelial CD8-positive T lymphocytes predict survival for patients with serous stage III ovarian carcinomas: relevance of clonal selection of T lymphocytes.
    Stumpf M; Hasenburg A; Riener MO; Jütting U; Wang C; Shen Y; Orlowska-Volk M; Fisch P; Wang Z; Gitsch G; Werner M; Lassmann S
    Br J Cancer; 2009 Nov; 101(9):1513-21. PubMed ID: 19861998
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.